Cause of death, by non-communicable diseases, ages 60+, male in Iraq
Iraq: Cause of death, by non-communicable diseases, ages 60+, male was 79.6% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 60+, male in Iraq, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 60+.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 60+, male in Iraq stood at 79.6%.
The figure is up 2.6% on the previous year and down 13.9% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 60+, male in Iraq peaked at 93.0% in 2019 and was at its lowest, 77.5%, in 2020.
That places Iraq 44th out of 185 countries with data for 2021, putting it in the top quarter.
Cause of death, by non-communicable diseases, ages 60+, male in Iraq, year by year
| Year | % of total male deaths ages 60+ | Change |
|---|---|---|
| 2000 | 91.8% | — |
| 2010 | 92.5% | +0.8% |
| 2015 | 90.2% | -2.4% |
| 2019 | 93.0% | +3.2% |
| 2020 | 77.5% | -16.7% |
| 2021 | 79.6% | +2.6% |
Iraq compared with similar countries
- Iraq's 79.6% is above the median for upper middle income countries, which is 67.7%, 1.2× the median. (55 countries reporting)
- Iraq's 79.6% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 70.5%, 1.1× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 91.8% | 91.8% | 91.8% | 1 |
| 2010s | 91.9% | 90.2% | 93.0% | 3 |
| 2020s | 78.5% | 77.5% | 79.6% | 2 |
Countries ranked near Iraq
More health data for Iraq
- Un projection of annual infant deaths, annual growth rate -1.4 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9773 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 898.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5,830 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.988 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0587 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9818 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 60+, male in Iraq?
- Cause of death, by non-communicable diseases, ages 60+, male in Iraq was 79.6% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 60+, male recorded in Iraq?
- The highest recorded value was 93.0% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 60+, male recorded in Iraq?
- The lowest recorded value was 77.5% in 2020.
- How does Iraq rank for cause of death, by non-communicable diseases, ages 60+, male?
- Iraq ranks 44th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 60+, male rising or falling in Iraq?
- Over the last ten years it is down 13.9%. The long-run trend across the full record is falling.
- Where does this Iraq data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.